(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-bromo-1H-indol-3-yl)propanoic acid, 98%, 250mg

Ethyl 4-amino-3-iodobenzoate, 95.0%, 10g

2-(chloromethyl)-4-oxo-1,4-dihydro-6-quinolinecarboxamide, 95.0%, 1g

3-Acetylindolizine-1-carboxylic acid, 95.0%, 5g

Naltrexone Hydrochloride>98.0%(HPLC)(GC)250mg

3-Bromo-4-chlorotoluene, 99.0%, 100g

7-Amino-1,3-dimethyl-2,4-dioxo-5-(pyridin-3-yl)-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile, 1g

(S)-2-tert-Butoxycarbonyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 95.0%, 10g

Spiro[indene-1,4'-piperidine], 95.0%, 5g

3-Chloro-2-methylbenzylamine, 95.0%, 5g

5-Bromo-1-methyl-1H-benzo[d][1,2,3]triazole, 95.0%, 250mg

4-Fluoro-3-formylbenzonitrile, 95.0%, 25g

3-Difluoromethanesulfonylbenzoic acid, 95%, 2.5g